Le Lézard
Classified in: Health, Science and technology, Business
Subjects: NPT, SVY, LIC, PSF

RTI International to coordinate national study to reduce opioid fatalities


RESEARCH TRIANGLE PARK, N.C., April 18, 2019 /PRNewswire/ -- RTI International (RTI), a non-profit research institute, will serve as the Data Coordinating Center (DCC) for the HEALing Communities Study. Four independent research sites, spanning more than 60 towns and counties in Kentucky, Massachusetts, New York and Ohio, will participate in the study to reduce opioid fatalities by at least 40 percent in three years.

The study is funded in partnership by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and the Substance Abuse and Mental Health Services Administration (SAMHSA). The study is part of the NIH HEAL (Helping to End Addiction Long-term) Initiative, a bold, trans-agency effort to speed scientific solutions to stem the national opioid crisis. 

The opioid crisis is devastating the United States, with rural states and communities being hit especially hard. Provisional data from 2017 show there were 49,068 opioid-related deaths in the U.S.?an approximate five-fold increase since 2000.

As the DCC, RTI will coordinate and pool data across the HEALing Communities Study to provide desperately needed actionable guidance to curb the death and devastation caused by the opioid crisis.

The study will test the effectiveness of implementing integrated evidence-based interventions in communities that have higher-than-average rates of opioid-related mortality. Each community will work across healthcare, behavioral health, justice and other community-based settings to prevent and treat opioid misuse and opioid use disorder.

"We look forward to working with NIDA, SAMHSA and the research sites to achieve the goal of this study and provide them with rigorous research to combat the epidemic in the most affected communities," said Rick Williams, PhD, a Principal Scientist at RTI. "We have more than 30 years of experience studying effective drug misuse prevention and treatment. Our team has a deep understanding of the opioid crisis."

RTI's team will be co-led by three principal investigators ? Dr. Williams (operations, informatics and analytics), Dr. Gary Zarkin (health economics research) and Dr. Kevin Conway (coordination and communication).

NIDA has committed over $350M to this landmark study. RTI's role as the DCC will leverage the institute's expertise in coordination and communication, data management, data science and analysis, and health economic research.

About RTI International
RTI International is an independent, nonprofit research institute dedicated to improving the human condition. Clients rely on us to answer questions that demand an objective and multidisciplinary approach?one that integrates expertise across the social and laboratory sciences, engineering, and international development. We believe in the promise of science, and we are inspired every day to deliver on that promise for the good of people, communities, and businesses around the world.  For more information, visit www.rti.org.

SOURCE RTI International


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: